A service of StreetInsider.com
Welcome

Most Popular

AAPL 222.25
C 3.90
GOOG 560.00
BAC 16.82
RIMM 73.06

Recently Added

WWIN 6.46
CCLTF 9.20
KCAP 5.51
NWM 0.01
CNYD 13.05

Gaining Speed

NWM 0.01
KCAP 5.51
CNYD 13.05
CCLTF 9.20
BRLI 43.85
2.59 -0.04 (-1.51%) CLRT

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:2.59 Change:-0.04 (-1.51%) Prev Close:2.63 Open: 2.65 Days Range:2.59 – 2.66 52 Week Range: 1.62 - 4.43 Volume:359393 P/E: N/A
EPS:-0.14





Recent Blog Posts

Blog Posts on 10/23/09 at 11:05am
Are We Re-Running 1999?
Blog Posts on 10/14/09 at 6:47am
With Promising Cancer Drugs, Genomic Must Still Diversify Its Pipeline
Blog Posts on 07/01/09 at 7:53am
Big Lineup of Healthcare Stocks Crack the Russell 3000 Index
Blog Posts on 05/05/09 at 2:36pm
Clarient: New Breast-Cancer Test
Blog Posts on 04/22/09 at 7:40am
Notes on CDS Market, De-Risking and Re-Risking
Blog Posts on 04/15/09 at 4:33pm
Clarient: A Fresh Start After Relief from Bad Debt
Blog Posts on 04/13/09 at 4:21am
Tracking Cancer Diagnostic and Therapeutic Stocks
Blog Posts on 12/26/08 at 2:23am
New Emerging Diagnostics Index
Blog Posts on 11/02/08 at 7:44am
Clarient: With Quarterly Revenues Up 59%, Take a Look
Blog Posts on 09/21/08 at 1:35am
Clarient, Inc. Q2 2008 Earnings Call Transcript
Blog Posts on 08/11/08 at 4:16am
Clarient: Clearly a Winner
Blog Posts on 05/13/08 at 5:58am
Interview with Jim Datin, Executive VP & Managing Director of Safeguard Scientifics
Blog Posts on 03/17/08 at 6:55am
Interview with Ron Andrews, President & CEO of Clarient
Blog Posts on 12/30/07 at 8:57am
Clarient, Inc.: Clarifying the Complexities of Cancer